Q/C TECHNOLOGIES, INC. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2019-12-09

Reporting Person: Hudson Bay Capital Management LP (10% Owner)
Reporting Person: Gerber Sander (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-09	Common Stock, no par value ("Common Stock")	P	19353	$2.96	Acquired	104018	Indirect
2019-12-09	Common Stock	P	50000	$2.99	Acquired	154018	Indirect
2019-12-10	Common Stock	P	30000	$2.97	Acquired	184018	Indirect
2019-12-11	Common Stock	P	26406	$3.1	Acquired	210424	Indirect
2019-12-11	Common Stock	P	6019	$3.05	Acquired	216443	Indirect
2019-12-12	Common Stock	P	20600	$2.98	Acquired	237043	Indirect
2019-12-13	Common Stock	P	6000	$3.02	Acquired	243043	Indirect
2019-12-16	Common Stock	P	5000	$3.07	Acquired	248043	Indirect
2019-12-17	Common Stock	P	3000	$3.03	Acquired	251043	Indirect
2019-12-18	Common Stock	P	7500	$3.07	Acquired	258043	Indirect
2019-12-19	Common Stock	P	2700	$3.08	Acquired	261243	Indirect
2019-12-20	Common Stock	P	8000	$3.02	Acquired	269243	Indirect

Footnotes

F1: The securities are held by Hudson Bay Master Fund, Ltd. (the "Fund"). Hudson Bay Capital Management LP (the "Investment Manager") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein.